Ragan Paula's Form 4 filing
X4 Pharmaceuticals, Inc (XFOR) · filed Jan 27, 2025
- Accession no.
- 0001628280-25-002709
- Filed
- Jan 27, 2025, 6:15 PM ET
- Trade date
- Jan 23-24, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $34.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ragan PaulaCIK 0001769914 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Common Stock | AGrant or awardAcquired | +169,940 | $0.00 | $0 | 1,163,859 | Direct | |
| Jan 24, 2025 | Common Stock | SSaleDisposed | −76,473 | $0.454 | −$34,718.74 | 1,087,386 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.